Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
This multi-center, post-marketing, observational study evaluates the real world safety and
 effectiveness of glecaprevir plus pibrentasvir use in participants infected with the
 hepatitis C virus genotype 1 - 6.
Inclusion Criteria:

 -  Patients with chronic hepatitis C virus infection and administering glecaprevir plus
 pibrentasvir.

 Exclusion Criteria:

 -  Patients previously treated with glecaprevir plus pibrentasvir.